DOCS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 07, 2026
Report Source: 2026 3rd Quarter Report
Doximity Inc. Stock Analysis DOCS
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 830 full-time employees. The company went IPO on 2021-06-24. The company offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
Read More Doximity Inc (DOCS) Chart
Key Statistics of Doximity Inc (DOCS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$17.95Volume
12.35MP/E Ratio (TTM)
15.7052 Week Range
Market Cap
4.76BAvg. Volume
4.86MDividend Yield
-Financial Metrics & Statements of Doximity Inc (DOCS)
FAQ's for Doximity Inc (DOCS)
- According to Musaffa’s Shariah screening methodology, Doximity Inc (DOCS) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.